Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder

James J. Gattuso, Geraldine Kong, Bilgenur Bezcioglu, Da Lu, Millicent N. Ekwudo, Carey Wilson, Carolina Gubert, Anthony J. Hannan, Thibault Renoir

Open source

DOI
10.1016/j.neuropharm.2025.110648
Published
2025-11
Container
Neuropharmacology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.neuropharm.2025.110648,
  title = {Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder},
  author = {James J. Gattuso and Geraldine Kong and Bilgenur Bezcioglu and Da Lu and Millicent N. Ekwudo and Carey Wilson and Carolina Gubert and Anthony J. Hannan and Thibault Renoir},
  year = {2025},
  journal = {Neuropharmacology},
  doi = {10.1016/j.neuropharm.2025.110648},
  url = {https://doi.org/10.1016/j.neuropharm.2025.110648}
}

RIS

TY  - JOUR
TI  - Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder
AU  - James J. Gattuso
AU  - Geraldine Kong
AU  - Bilgenur Bezcioglu
AU  - Da Lu
AU  - Millicent N. Ekwudo
AU  - Carey Wilson
AU  - Carolina Gubert
AU  - Anthony J. Hannan
AU  - Thibault Renoir
PY  - 2025
JO  - Neuropharmacology
DO  - 10.1016/j.neuropharm.2025.110648
UR  - https://doi.org/10.1016/j.neuropharm.2025.110648
ER  - 

APA

Gattuso, J. J., Kong, G., Bezcioglu, B., Lu, D., Ekwudo, M. N., Wilson, C., Gubert, C., Hannan, A. J., & Renoir, T. (2025). Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2025.110648

Source records